Correction: Differentiating HER2-low and HER2-zero tumors with 21-gene multigene assay in 2,295 HR + HER2- breast cancer: a retrospective analysis

Breast Cancer Res. 2024 Nov 26;26(1):164. doi: 10.1186/s13058-024-01929-z.

Yoonwon Kook^#^{1

2}, Young-Jin Lee^#³, Chihhao Chu^#^{1

2}, Ji Soo Jang^{1

2}, Seung Ho Baek^{1

2}, Soong June Bae^{1

2}, Yoon Jin Cha^{2

4}, Gyungyup Gong⁵, Joon Jeong^{1

2}, Sae Byul Lee⁶, Sung Gwe Ahn^{7

8}

¹ Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, 712 Eonjuro, Gangnam-gu, Seoul, 06273, Republic of Korea.
² Institute for Breast Cancer Precision Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
³ Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
⁴ Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
⁵ Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
⁶ Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. [email protected].
⁷ Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, 712 Eonjuro, Gangnam-gu, Seoul, 06273, Republic of Korea. [email protected].
⁸ Institute for Breast Cancer Precision Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. [email protected].

^# Contributed equally.

No abstract available

Publication types